REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Specjalistyczny Zespol Gruzlicy I Chorob Pluc (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Specjalistyczny Zespol Gruzlicy I Chorob Pluc Profile Updated: June 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Specjalistyczny Zespol Gruzlicy I Chorob Pluc is based in Poland. The head office is in Koszalin. The company operates in the General Medical and Surgical Hospitals sector. The enterprise was incorporated on June 21, 2001. The total number of employees is currently 180 (2003). The company’s latest financial report indicates a net sales revenue increase of 16.36% in 2024. Its’ total assets recorded a negative growth of 4.55%. The net profit margin of Specjalistyczny Zespol Gruzlicy I Chorob Pluc decreased by 0.71% in 2024.

Headquarters
Ul. Niepodleglosci 44-48
Koszalin; Zachodniopomorskie; Postal Code: 75-252

Contact Details: Purchase the Specjalistyczny Zespol Gruzlicy I Chorob Pluc report to view the information.

Website: http://www.wz.wzp.pl

Basic Information
Total Employees:
Purchase the Specjalistyczny Zespol Gruzlicy I Chorob Pluc report to view the information.
Financial Auditors:
Purchase the Specjalistyczny Zespol Gruzlicy I Chorob Pluc report to view the information.
Incorporation Date:
June 21, 2001
Key Executives
Purchase this report to view the information.
Kierownik Samodzielnego Publicznego Zakladu Opieki Zdrowotnej
Company Performance
Financial values in the chart are available after Specjalistyczny Zespol Gruzlicy I Chorob Pluc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
16.36%▲
Total Operating Revenue
21.56%▲
Operating Profit
-37.64%▼
EBITDA
86.27%▲
Net Profit/Loss for the Period
-39.34%▼
Total Assets
-4.55%▼
Total Equity
-70.33%▼
Operating Profit Margin
-0.64%▼
Net Profit Margin
-0.71%▼
Return on Equity (ROE)
-102.61%▼
Quick Ratio
-0.01%▼
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo